MIGNONE ROBERTO
Insider CIK 1258394 · RGDX 10% owner · TROV 10% owner · PFSI · GH Director · AVAN Director · TEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| GH Guardant Health, Inc. | M Exercise deriv | 2026-10-21 | 2026-10-22 | 264 | — | $0 | 6,336 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-10-21 | 2026-10-22 | 264 | — | $0 | 10,538 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-09-21 | 2026-09-22 | 264 | — | $0 | 6,600 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-09-21 | 2026-09-22 | 264 | — | $0 | 10,274 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-09-21 | 2026-09-22 | 264 | — | $0 | 6,600 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-09-21 | 2026-09-22 | 264 | — | $0 | 10,274 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 367,600 | $39.06 | $14.36M | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2026-09-18 | 2026-09-22 | 367,600 | $39.06 | $14.36M | 0 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-08-21 | 2026-08-24 | 264 | — | $0 | 6,864 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-08-21 | 2026-08-24 | 264 | — | $0 | 10,010 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-08-21 | 2026-08-24 | 264 | — | $0 | 6,864 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-08-21 | 2026-08-24 | 264 | — | $0 | 10,010 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-07-21 | 2026-07-22 | 264 | — | $0 | 7,128 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-07-21 | 2026-07-22 | 264 | — | $0 | 9,746 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-06-21 | 2026-06-23 | 264 | — | $0 | 7,392 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-06-21 | 2026-06-23 | 264 | — | $0 | 9,482 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-06-17 | 2026-06-22 | 4,203 | — | $0 | 0 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 2,711 | — | $0 | 2,711 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-06-17 | 2026-06-22 | 4,203 | — | $0 | 8,954 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2026-06-05 | 2026-06-08 | 14,492 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2026-06-05 | 2026-06-08 | 14,492 | — | $0 | 119,807 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2026-05-28 | 2026-06-01 | 7,242 | — | $0 | 7,242 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-05-21 | 2026-06-23 | 264 | — | $0 | 7,656 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-05-21 | 2026-06-23 | 264 | — | $0 | 9,218 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-04-21 | 2026-04-22 | 264 | — | $0 | 7,920 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-04-21 | 2026-04-22 | 264 | — | $0 | 4,751 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-03-21 | 2026-03-23 | 264 | — | $0 | 8,184 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-03-21 | 2026-03-23 | 264 | — | $0 | 4,487 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-02-21 | 2026-02-23 | 264 | — | $0 | 8,448 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-02-21 | 2026-02-23 | 264 | — | $0 | 4,223 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2026-01-21 | 2026-01-22 | 264 | — | $0 | 8,712 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2026-01-21 | 2026-01-22 | 264 | — | $0 | 3,959 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-12-21 | 2025-12-23 | 264 | — | $0 | 8,976 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-12-21 | 2025-12-23 | 264 | — | $0 | 3,695 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-12-16 | 2025-12-18 | 77,400 | $30.24 | $2.34M | 367,600 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-11-26 | 2025-12-01 | 50,000 | $26.03 | $1.30M | 445,000 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-11-21 | 2025-11-24 | 264 | — | $0 | 9,240 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-11-21 | 2025-11-24 | 264 | — | $0 | 3,431 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2025-11-06 | 2025-11-10 | 200,000 | $24.11 | $4.82M | 495,000 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise deriv | 2025-10-21 | 2025-10-22 | 3,167 | — | $0 | 9,504 | SEC↗ |
| GH Guardant Health, Inc. | M Exercise | 2025-10-21 | 2025-10-22 | 3,167 | — | $0 | 3,167 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 4,203 | — | $0 | 4,203 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2025-06-18 | 2025-06-20 | 6,833 | — | $0 | 6,833 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2025-06-06 | 2025-06-09 | 9,632 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2025-06-06 | 2025-06-09 | 9,632 | — | $0 | 105,315 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2025-06-05 | 2025-06-09 | 14,492 | — | $0 | 14,492 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-12-20 | 2024-12-26 | 286,000 | $22.01 | $6.29M | 695,000 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2024-11-08 | 2024-11-12 | 19,535 | — | $0 | 19,535 | SEC↗ |
| GH Guardant Health, Inc. | A Award deriv | 2024-11-08 | 2024-11-12 | 12,671 | — | $0 | 12,671 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | S Sale | 2024-06-18 | 2024-06-21 | 519,000 | $17.03 | $8.84M | 981,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2024-06-15 | 2024-06-17 | 21,108 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2024-06-15 | 2024-06-17 | 21,108 | — | $0 | 1,595,683 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2024-06-06 | 2024-06-10 | 9,632 | — | $0 | 9,632 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2023-08-04 | 2023-08-07 | 15,810 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2023-08-04 | 2023-08-07 | 15,810 | — | $0 | 1,574,575 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2023-06-15 | 2023-06-20 | 21,108 | — | $0 | 21,108 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2022-08-04 | 2022-08-08 | 15,810 | — | $0 | 15,810 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2022-06-14 | 2022-06-16 | 14,479 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2022-06-14 | 2022-06-16 | 14,479 | — | $0 | 58,765 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2021-06-14 | 2021-06-16 | 14,479 | — | $0 | 14,479 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-09 | 2021-06-10 | 12,668 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-09 | 2021-06-10 | 12,668 | — | $0 | 44,286 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2021-06-05 | 2021-06-08 | 6,041 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2021-06-05 | 2021-06-08 | 6,041 | — | $0 | 31,618 | SEC↗ |
| AVAN Avanti Acquisition Corp. | P Buy | 2020-10-01 | 2020-10-05 | 1,000,000 | $10.00 | $10.00M | 1,000,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-08-11 | 2020-08-13 | 7,956 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-08-11 | 2020-08-13 | 7,956 | — | $0 | 25,577 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise deriv | 2020-06-11 | 2020-06-15 | 17,621 | — | $0 | 0 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | M Exercise | 2020-06-11 | 2020-06-15 | 17,621 | — | $0 | 17,621 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2020-06-09 | 2020-06-11 | 12,668 | — | $0 | 12,668 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2019-06-11 | 2019-06-13 | 17,621 | — | $0 | 17,621 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | A Award deriv | 2018-06-05 | 2018-06-07 | 6,041 | — | $0 | 6,041 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | P Buy | 2018-05-10 | 2018-05-11 | 250,000 | $19.32 | $4.83M | 1,500,000 | SEC↗ |
| TEVA TEVA PHARMACEUTICAL INDUST | P Buy | 2018-05-09 | 2018-05-11 | 500,000 | $19.21 | $9.61M | 1,250,000 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2016-11-11 | 2016-11-15 | 322,472 | $3.08 | $993.2K | 2,968,115 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-18 | 2015-11-20 | 2,841,255 | — | $0 | 0 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-18 | 2015-11-20 | 1,793,745 | — | $0 | 0 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-17 | 2015-11-17 | 232,940 | — | $0 | 2,841,255 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-17 | 2015-11-17 | 147,060 | — | $0 | 1,793,745 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-16 | 2015-11-17 | 183,905 | — | $0 | 3,074,195 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-16 | 2015-11-17 | 116,095 | — | $0 | 1,940,805 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-13 | 2015-11-17 | 547,100 | — | $0 | 2,056,900 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-13 | 2015-11-17 | 47,900 | — | $0 | 3,258,100 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-11 | 2015-11-12 | 30,000 | — | $0 | 2,604,000 | SEC↗ |
| RGDX RESPONSE GENETICS INC | D To issuer | 2015-11-10 | 2015-11-12 | 60,000 | — | $0 | 2,634,000 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2015-07-17 | 2015-07-21 | 140,000 | $8.75 | $1.23M | 3,290,587 | SEC↗ |
| RGDX RESPONSE GENETICS INC | J Other deriv | 2015-04-03 | 2015-04-07 | 1,351,352 | — | $0 | 1,351,352 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2015-04-02 | 2015-04-06 | 300,000 | $6.90 | $2.07M | 3,150,587 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2015-02-27 | 2015-02-27 | 79,343 | $5.62 | $445.9K | 2,850,587 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2015-02-26 | 2015-02-27 | 78,801 | $5.42 | $427.1K | 2,771,244 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2015-02-25 | 2015-02-27 | 105,142 | $5.12 | $538.3K | 2,692,443 | SEC↗ |
| TROV Trovagene, Inc. | P Buy | 2015-02-06 | 2015-02-10 | 444,444 | $4.50 | $2.00M | 2,587,301 | SEC↗ |
| RGDX RESPONSE GENETICS INC | P Buy | 2012-09-13 | 2012-09-17 | 3,000,000 | $1.10 | $3.30M | 6,000,000 | SEC↗ |